-
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
02 Jul 2025 11:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … as lead counsel to Ligand. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems
01 Jul 2025 14:40 GMT
… CD47, a cell surface ligand that binds to immune cells … responses, according to Pfizer’s website.
Pfizer gained ownership of maplirpacept … , including multiple myeloma.
The pharma also has a Phase I … Then, in July 2023, the pharma terminated a late-stage study …
-
Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline | DelveInsight
20 Jun 2025 00:25 GMT
… clinical outcomes.
Delta-like Ligand 3 Targeted Therapies Epidemiology Segmentation … Therapeutic Assessment: Delta-like Ligand 3 Targeted Therapies current marketed … Boehringer Ingelheim International GmbH, Pfizer, Inc., Ipsen Pharma, AVEO Oncology, Hutchison …
-
Ligand Announces 2025 Investor Day in New York City
11 Jun 2025 11:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … to the event. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
PD-1+ NSCLC Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
30 May 2025 02:01 GMT
… the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of ES102 … mutation and programmed cell death ligand 1 (PD-L1) tumor … Akeso Biopharma, Biotheus, GlaxoSmithKline, AstraZeneca, Pfizer, Shandong Boan Biotechnology, Genor Biopharma …
-
The Estrogen Receptor Modulators Global Market Is On An Upward Trajectory, Projected To Reach $17.12 Billion In 2025
03 Jul 2025 11:27 GMT
…
Well-established firms such as Pfizer Inc., Johnson & Johnson … Pharmaceuticals Co. Ltd., Aurobindo Pharma, Alkem Laboratories Ltd., Atossa Therapeutics, Ligand Pharmaceuticals, … For instance, Pfizer Inc., a US-based pharmaceutical and biotech company …
-
Metastatic Colorectal Cancer Pipeline Appears Robust With 150+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
22 May 2025 04:37 GMT
… tumours. HLX10 has exhibited better pharmacokinetics, pharmacodynamics properties, favourable safety, tolerability profile … expected to inhibit not only ligand-dependent activation but also … Products (Phase II)
Axitinib: Pfizer
Drug profiles in the detailed …
-
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025
14 May 2025 11:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … bell-ringing-ceremony. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
Ligand Reports First Quarter 2025 Financial Results
08 May 2025 11:00 GMT
… at www.ligand.com. About Ligand Pharmaceuticals Ligand is a … leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz …
[Tables Follow]
LIGAND PHARMACEUTICALS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF …
-
Ligand to Participate in May Investor Conferences
01 May 2025 11:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … Craig-Hallum representative. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
About
© 1995-2025